BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8905323)

  • 1. Systemic administration of dynorphin A-(1-13) markedly improves cycloheximide-induced amnesia in mice.
    Ukai M; Shan-Wu X; Kobayashi T; Kameyama T
    Eur J Pharmacol; 1996 Oct; 313(1-2):11-5. PubMed ID: 8905323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the kappa-opioid dynorphin A(1-13) on learning and memory in mice.
    Ukai M; Itoh J; Kobayashi T; Shinkai N; Kameyama T
    Behav Brain Res; 1997 Feb; 83(1-2):169-72. PubMed ID: 9062678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. U-50,488H, a kappa-opioid receptor agonist, markedly prevents memory dysfunctions induced by transient cerebral ischemia in mice.
    Itoh J; Ukai M; Kameyama T
    Brain Res; 1993 Aug; 619(1-2):223-8. PubMed ID: 8397052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynorphin A-(1-13) potently improves scopolamine-induced impairment of passive avoidance response in mice.
    Ukai M; Kobayashi T; Shinkai N; Shan-Wu X; Kameyama T
    Eur J Pharmacol; 1995 Feb; 274(1-3):89-93. PubMed ID: 7768285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. U-50488H, a selective kappa-opioid receptor agonist, improves carbon monoxide-induced delayed amnesia in mice.
    Hiramatsu M; Hyodo T; Kameyama T
    Eur J Pharmacol; 1996 Nov; 315(2):119-25. PubMed ID: 8960874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dynorphin A-(1-13) on carbon monoxide-induced delayed amnesia in mice studied in a step-down type passive avoidance task.
    Hiramatsu M; Sasaki M; Kameyama T
    Eur J Pharmacol; 1995 Aug; 282(1-3):185-91. PubMed ID: 7498274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynorphin A-(1-13) potently improves galanin-induced impairment of memory processes in mice.
    Kameyama T; Ukai M; Miura M
    Neuropharmacology; 1994 Oct; 33(10):1167-9. PubMed ID: 7532287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kappa opioid receptor activity modulates memory for peck-avoidance training in the 2-day-old chick.
    Colombo PJ; Martinez JL; Bennett EL; Rosenzweig MR
    Psychopharmacology (Berl); 1992; 108(1-2):235-40. PubMed ID: 1357708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of morphine reward through the activation of kappa-opioid receptors in mice.
    Funada M; Suzuki T; Narita M; Misawa M; Nagase H
    Neuropharmacology; 1993 Dec; 32(12):1315-23. PubMed ID: 7908722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. kappa-Opioid receptor agonists improve pirenzepine-induced disturbance of spontaneous alternation performance in the mouse.
    Ukai M; Shinkai N; Kameyama T
    Eur J Pharmacol; 1995 Aug; 281(2):173-8. PubMed ID: 7589204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA; Burks TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the opioid receptors involved in passive-avoidance learning in the day-old chick during the second wave of neuronal activity.
    Freeman FM; Young IG
    Brain Res; 2000 May; 864(2):230-9. PubMed ID: 10802030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynorphin A-(1-13) and (2-13) improve beta-amyloid peptide-induced amnesia in mice.
    Hiramatsu M; Inoue K; Kameyama T
    Neuroreport; 2000 Feb; 11(3):431-5. PubMed ID: 10718289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Participation of central kappa-opioid receptor in arrhythmogenesis.
    Lishmanov YB; Maslov LN; Ugdyzhekova DS; Smagin GN
    Life Sci; 1997; 61(3):PL33-8. PubMed ID: 9217295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioural effect of pretreatment with opioid antagonists and sigma binding site ligands on the abnormal motor response produced by the kappa opioid agonist U50,488H in guinea pigs.
    Brent PJ
    Neuropharmacology; 1993 Aug; 32(8):751-60. PubMed ID: 8413839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dynorphin A (1-13) on carbon monoxide-induced delayed amnesia in mice.
    Hiramatsu M; Sasaki M; Nabeshima T; Kameyama T
    Pharmacol Biochem Behav; 1997 Jan; 56(1):73-9. PubMed ID: 8981612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of peripheral kappa opioid receptors inhibits capsaicin-induced thermal nociception in rhesus monkeys.
    Ko MC; Butelman ER; Woods JH
    J Pharmacol Exp Ther; 1999 Apr; 289(1):378-85. PubMed ID: 10087027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line is coupled to adenylyl cyclase through a pertussis toxin-sensitive guanine nucleotide-binding regulatory protein.
    Lawrence DM; Bidlack JM
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1678-83. PubMed ID: 8103800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local inhibitory effects of dynorphin A-(1-17) on capsaicin-induced thermal allodynia in rhesus monkeys.
    Ko MC; Willmont KJ; Burritt A; Hruby VJ; Woods JH
    Eur J Pharmacol; 2000 Aug; 402(1-2):69-76. PubMed ID: 10940359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen and progesterone activate spinal kappa-opiate receptor analgesic mechanisms.
    Dawson-Basoa ME; Gintzler AR
    Pain; 1996 Jan; 64(1):169-177. PubMed ID: 8867260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.